Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-042439

Chairman and CEO bought 2,250 shares at $1.59 ($3,578)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-06-18 Purchase +500 $1.59 $795 10,764,121 D
Niihara Yutaka Chairman and CEO 2021-06-21 Purchase +1,250 $1.59 $1,988 10,765,371 D
Niihara Yutaka Chairman and CEO 2021-06-22 Purchase +500 $1.59 $795 10,765,871 D
Open-market purchases · 2,250 sh · avg $1.59 · $3,578
Loading xslF345X03/doc4.xml…